Concepedia

Publication | Open Access

Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study

DOIFull Paper Access

81

Citations

37

References

2013

Year

J. L. Boxerman, Zheng Zhang, Yair Safriel, Mykol Larvie, Bradley S. Snyder, Rajan Jain, A. Gregory Sorensen, Mark R. Gilbert, Daniel P. Barboriak
Neuro-Oncology

Abstract

Early progression on 2D-T1 and 3D-T1, but not FLAIR MRI, after 8 and 16 weeks of anti-vascular endothelial growth factor therapy has highly significant prognostic value for OS in recurrent GBM.

References

YearCitations

Page 1